Department of Radiotherapy, Wenzhou Central Hospital & The Dingli Clinical Institute of Wenzhou Medical University, Wenzhou 325000, PR China.
Second Department of Oncology, Wenzhou Central Hospital, Wenzhou 325000, PR China.
Int Immunopharmacol. 2024 May 10;132:111866. doi: 10.1016/j.intimp.2024.111866. Epub 2024 Apr 10.
Nasopharyngeal carcinoma (NPC) remains a challenging cancer to treat. This study investigates the molecular mechanisms of Hedyotis diffusa Willd (HDW) combined with Andrographis paniculata (AP) in treating NPC.
Key compounds and target genes in HDW and AP were analyzed using network pharmacology. Protein-protein interaction (PPI) networks were constructed with STRING and visualized using Cytoscape. MCODE identified critical clusters, while DAVID facilitated GO and KEGG analyses. In vivo and in vitro experiments evaluated HDW-AP effects on NPC, including tumor volume, weight, Ki-67 expression, cell apoptosis, migration, invasion, cell cycle distribution, and DNA damage.
The database identified 495 NPC-related genes and 26 compounds in the HDW-AP pair, targeting 165 genes. Fifty-eight potential therapeutic genes were found, leading to 18 key targets. KEGG analysis revealed a significant impact on 78 pathways, especially cancer pathways. Both in vivo and in vitro tests showed HDW-AP inhibited NPC cell proliferation, migration, invasion, and induced apoptosis. Mechanistically, this was achieved through AKT1 downregulation and VEGFA upregulation.
The combination of HDW and AP targets 16 key genes to impede the development of NPC, primarily by modulating AKT1 and VEGFA pathways.
鼻咽癌(NPC)仍然是一种具有挑战性的癌症治疗方法。本研究探讨了白花蛇舌草(HDW)联合穿心莲(AP)治疗 NPC 的分子机制。
采用网络药理学分析 HDW 和 AP 中的关键化合物和靶基因。使用 STRING 构建蛋白质-蛋白质相互作用(PPI)网络,并使用 Cytoscape 可视化。MCODE 识别关键簇,而 DAVID 则促进 GO 和 KEGG 分析。体内和体外实验评估了 HDW-AP 对 NPC 的影响,包括肿瘤体积、重量、Ki-67 表达、细胞凋亡、迁移、侵袭、细胞周期分布和 DNA 损伤。
该数据库鉴定出 495 个 NPC 相关基因和 HDW-AP 对中的 26 个化合物,靶向 165 个基因。发现了 58 个潜在的治疗基因,导致 18 个关键靶标。KEGG 分析显示,该化合物对 78 条途径,特别是癌症途径有显著影响。体内和体外试验均表明,HDW-AP 抑制 NPC 细胞增殖、迁移和侵袭,并诱导细胞凋亡。其机制是通过下调 AKT1 和上调 VEGFA 实现的。
HDW 和 AP 的组合靶向 16 个关键基因,通过调节 AKT1 和 VEGFA 途径来阻碍 NPC 的发展。